
|Articles|May 25, 2018
Osteoporosis Drug Approval Highlights AJPB Week in Review
Author(s)AJPB staff
Top news of the week from The American Journal of Pharmacy Benefits.
Advertisement
5. FDA Grants Breakthrough Therapy, Fast Track Designations to Narcolepsy Treatment
The FDA has granted Harmony Biosciences a Breakthrough Therapy designation for pitolisant, an investigational therapy for the treatment of cataplexy in patients with narcolepsy.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists Can Close the LDL Control Gap in Lipid Care
2
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
3
Cancer Among 9/11 Survivors Is Accelerating 25 Years Later
4
Expanding Contraceptive Prescribing Authority in Wisconsin to Increase Birth Control Access
5


































































































